Codeine is an opioid medicine used for pain and, in some countries and formulations, cough or diarrhea. It can cause sedation, respiratory depression, tolerance and physical dependence. Opioid use disorder is a separate clinical diagnosis based on a pattern of impaired control, craving, continued use despite harm and related features, not on physical dependence alone.
Tolerance and physical dependence can develop during prescribed use, but they do not inevitably progress to addiction. Codeine can nevertheless cause opioid use disorder and potentially fatal overdose, particularly when doses are increased without medical guidance or when it is combined with alcohol, benzodiazepines or other sedatives.
Opioid use disorder is treatable. Care should be based on an individual assessment and may include buprenorphine, methadone or naltrexone, psychosocial support, treatment of co-occurring conditions and overdose-prevention planning. Withdrawal management can be part of care, but detoxification alone is not recommended for opioid use disorder because it does not provide continuing treatment and can increase overdose risk after tolerance falls.
Consider a confidential professional assessment if codeine use is difficult to control, causes harm, produces cravings or withdrawal, or continues despite health, relationship, work or safety problems. Urgent help is needed for slow or stopped breathing, blue or gray lips or fingertips, collapse, or inability to wake.
Causing harm to others or yourself
Codeine can impair alertness, coordination and judgment. Seek help if use is contributing to unsafe driving, accidents, risky situations, self-harm thoughts or harm to other people. An immediate danger or suspected overdose requires emergency services.
Unable to stop on your own
People who develop codeine addiction or opioid use disorder may find it difficult to cut down or stop despite wanting to do so. Physical dependence means abrupt reduction can cause withdrawal; it does not mean the body literally needs codeine for survival or that addiction is present. If attempts to reduce or stop have not worked, a clinician can assess withdrawal risk and discuss evidence-based treatment and support.
Experiencing severe side effects/consequences
Opioid use disorder can affect health, relationships, study, work, finances and daily responsibilities. Continuing to use codeine despite these problems is a reason to seek assessment; treatment can be adapted to the severity of symptoms and the person’s circumstances.
Allowing your life to revolve around codeine use
Spending substantial time obtaining, using or recovering from codeine, strong cravings, and giving up important activities are recognized features of opioid use disorder. A qualified professional can assess these signs without judgment and explain available levels of care.
Before commencing treatment at a rehab, an addiction specialist will assess your addiction’s severity and use this information to decide on an appropriate level of care. The assessment involves various questions, such as:
- How long ago did you start using codeine
- How much codeine do you normally use, and how often?
- Do you use codeine when you are uncomfortable or stressed?
- Do you use codeine more in certain circumstances?
- Do you also use any other substance along with codeine?
- Have you been diagnosed with a mental health disorder?
- Are you currently experiencing any symptoms of withdrawal?
- Is there anything noteworthy in your medical history?
- When did you take the last dose of codeine?
Accurate information helps the clinical team plan safe, appropriate care. Assessment commonly covers current and recent substance use, prescribed medicines, withdrawal and overdose history, physical and mental health, pregnancy where relevant, social circumstances and immediate safety. Examination or toxicology testing may be used when clinically indicated, but a test result does not by itself diagnose opioid use disorder or determine the right level of care.
Assessment should include co-occurring mental-health symptoms and other medical or social needs so they can be addressed alongside opioid treatment. The plan should be reviewed with the person and adjusted as needs change.
When opioid use disorder is suspected, professional assessment can identify evidence-based treatment options and longer-termrelapse prevention. Abruptly stopping after regular use can cause withdrawal, and loss of tolerance raises overdose risk if opioid use resumes; a clinician can help plan safer care. The first step is a clinical assessment and an individualized plan. When opioid use disorder is diagnosed, the plan should include access to medication where appropriate, overdose prevention and continuing support. Completing detoxification is not a prerequisite for treatment with buprenorphine or methadone.
During medically supported withdrawal care, clinicians may use medication and supportive care to reduce withdrawal symptoms while beginning or continuing treatment for opioid use disorder. The timing and duration of withdrawal vary with dose, duration of use, other substances, health conditions and individual metabolism; symptoms should not be predicted from a fixed timetable. Some common symptoms of codeine withdrawal include:
- Headaches
- Muscle aches
- Insomnia
- Chills or gooseflesh
- Vomiting and nausea
- Stomach pains
- Sweating
- Diarrhea
- Anxiety, restlessness, or low mood
- Dehydration caused by vomiting or diarrhea
- Intense cravings for codeine
Opioid withdrawal is often intensely uncomfortable and can cause complications such as dehydration. Risk varies with the pattern of use, other medicines or substances, pregnancy, co-occurring conditions and overall health. Clinical assessment can determine whether outpatient support, more intensive monitoring or another level of care is appropriate.
Medications have different roles in codeine addiction treatment. Buprenorphine or methadone can manage withdrawal and cravings and may be continued as ongoing treatment for opioid use disorder. Naltrexone is used only after an adequate opioid-free interval confirmed by a clinician; it does not treat acute opioid withdrawal.
Naltrexone
Naltrexone blocks opioid effects and can help prevent relapse after a clinician confirms that opioids have cleared sufficiently. Starting it while a person remains opioid-dependent can trigger sudden, severe withdrawal. It should not be started during active codeine withdrawal.
Methadone
Methadone is a full opioid agonist used to treat opioid use disorder. When provided through an appropriately regulated program, it can reduce withdrawal and cravings and may be continued as long-term treatment; it is not merely a short detoxification medicine.
Buprenorphine
Buprenorphine is a partial opioid agonist used to treat opioid use disorder. An appropriately timed, clinician-guided start can reduce withdrawal and cravings, and continuing treatment lowers overdose and mortality risk. It can itself cause physical dependence and must be used as prescribed.
Cravings, sleep disturbance, anxiety or low mood can persist or recur, but their course varies and these symptoms may have several causes. Ongoing follow-up can address medication, mental health, relapse risk and social needs. New or worsening suicidal thoughts require urgent professional or emergency help.
Treatment does not need to wait until detoxification is complete. Medication for opioid use disorder, psychosocial care and support for co-occurring conditions can begin as part of one coordinated plan. The appropriate setting may be outpatient, intensive outpatient, residential or inpatient depending on clinical and safety needs.
Residential or inpatient care provides a structured setting and closer monitoring for people whose medical, psychiatric, social or safety needs cannot be managed adequately in outpatient care. It is not automatically more effective for everyone; placement should follow an individualized assessment and be reviewed as needs change.
Outpatient care allows a person to live at home while attending scheduled treatment. The frequency and combination of services vary and should be matched to individual needs. Services may include:
- Codeine abuse education
- Life skills education
- Individual, group, and family therapy
- Cravings and triggers management
- Mental health treatment (dual diagnosis)
- 12-step programs and meetings
- Cognitive-behavioral therapy (CBT)
- Transitional living facility referrals (such as sober living homes)
- Training for relapse prevention
Intensive outpatient programs provide more frequent support than standard outpatient care without overnight residence. Definitions and schedules vary by country and provider, so placement should be based on clinical need, safety, local standards and the person’s ability to participate.
At THE BALANCE, treatment is designed to support both physical recovery and emotional healing. Our team understands how codeine addiction affects the brain, the body, and daily life. We provide private assessment, medically supported withdrawal care where indicated, therapy and continuing-care planning in a calm environment. Every treatment plan is built around the patient’s needs, comfort, and long-term goals.
When withdrawal care is needed, medical staff monitor symptoms and complications. Medication for opioid use disorder, therapy and support for co-occurring conditions can overlap rather than waiting for a separate detoxification phase to end. Treatment explores the person’s goals, risks, strengths and relevant psychological or social factors.
Private accommodation, wellness activities and individual attention may make residential care more comfortable, but clinical outcomes depend on appropriate evidence-based treatment, engagement and continuing support. The setting is one part of an individualized program.
Before discharge or transition, the team develops a continuing-care plan that may include medication, therapy, overdose-prevention measures, relapse-risk planning and links to local support. Recovery is individual and ongoing; follow-up should be adjusted when needs or risks change.
